Pre-clinical development of chimeric antigen receptor T-cell immunotherapy: Implications of design for efficacy and safety. (2018)
Attributed to:
Immunotherapy of Epithelial Ovarian Cancer using Autologous Gamma Delta T-cells
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.beha.2018.04.002
PubMed Identifier: 29909912
Publication URI: http://europepmc.org/abstract/MED/29909912
Type: Journal Article/Review
Volume: 31
Parent Publication: Best practice & research. Clinical haematology
Issue: 2
ISSN: 1521-6926